Novavax Inc. Stock Rises 4.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. advanced 4.0% to $10.83 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,244.28 and the Dow Jones Industrial Average falling 0.4% to 51,863.69.

This was the stock's fifth consecutive day of gains.

Novavax Inc. closed 9.5% short of its 52-week high of $11.97, which the company achieved on February 26th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.1% to $269.19, Pfizer Inc. rose 0.7% to $27.93, and Merck & Co. Inc. rose 0.94% to $150.91.

Trading volume totaled 7.6 million, compared to the 50-day average of 4.5 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 22, 2026 16:35 ET (20:35 GMT)